BioCryst Pharmaceuticals BCRX Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $91.34M-14.1% | $106.32M-5.4% | $112.45M-63.1% | $304.77M-39.6% | ||
| $185.01M-14.4% | $216.14M-22.3% | $278.34M+133% | $119.54M+3,622% | ||
| $106.82M+35.1% | $79.07M+3,344% | $2.3M-72.2% | $8.27M-71.9% | ||
| $23.99M+3.5% | $23.19M— | $0-100% | $28.71M+81.8% | ||
| $404.35M-4.2% | $421.97M-14.9% | $495.97M-4.0% | $516.5M-8.8% | ||
| $8.78M+12.9% | $7.78M-1.7% | $7.91M-8.2% | $8.62M-1.1% | ||
| $514.16M+4.8% | $490.42M-5.1% | $516.96M-6.0% | $550M-6.5% | ||
| $15.83M+35.9% | $11.64M-44.3% | $20.89M+45.5% | $14.36M-48.4% | ||
| $0— | —— | $0-100% | $1.22M-13.9% | ||
| $1.31M-28.5% | $1.84M+15.4% | $1.59M+86.4% | $853K— | ||
| $196.07M+22.2% | $160.38M+6.9% | $149.99M+42.1% | $105.51M+1.7% | ||
| $0-100% | $314.87M+3.8% | $303.23M+30.9% | $231.62M+70.2% | ||
| $633.31M-34.5% | $966.35M-0.6% | $972.49M— | —— | ||
| 450M+21,483% | 2.1M+1.3% | 2.1M+9.5% | 1.9M+2.0% | ||
| -$1.51B+14.9% | -$1.77B-5.3% | -$1.68B-15.6% | -$1.45B-20.5% | ||
| -$119.15M+75.0% | -$475.93M-4.5% | -$455.53M-54.6% | -$294.6M-175% | ||
| $514.16M+4.8% | $490.42M-5.1% | $516.96M-6.0% | $550M-6.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are BioCryst Pharmaceuticals's total assets?
- BioCryst Pharmaceuticals (BCRX) holds $465.1M in total assets, down 3.1% year over year.
- How much debt does BioCryst Pharmaceuticals have?
- BioCryst Pharmaceuticals carries $411.8M in total debt against -$553.8M of shareholders' equity, a debt-to-equity ratio of 0.14.
- How much cash does BioCryst Pharmaceuticals have?
- BioCryst Pharmaceuticals holds $173.4M in cash and equivalents.
- Can BioCryst Pharmaceuticals cover its short-term obligations?
- Its current ratio is 1.91 — current assets exceed current liabilities.
- Where does BioCryst Pharmaceuticals's balance sheet data come from?
- Every line is extracted from BioCryst Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
